A Regional Network Organization for Thrombectomy for Acute Ischemic Stroke in the Anterior Circulation; Timing, Safety, and Effectiveness.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 03 08 2018
revised: 19 09 2018
accepted: 27 09 2018
pubmed: 18 11 2018
medline: 29 1 2019
entrez: 17 11 2018
Statut: ppublish

Résumé

Mechanical thrombectomy (MT) in association with intravenous thrombolysis is recommended for treatment of acute ischemic stroke (AIS), with large vessel occlusion (LVO) in the anterior circulation. Because MT is only available in comprehensive stroke centers (CSC), the challenge of stroke organization is to ensure equitable access to the fastest endovascular suite. Our aim was to evaluate the feasibility, efficacy, and safety of MT in patients initially managed in 1 CSC (mothership), compared with patients first managed in primary stroke center (PSC), and then transferred to the CSC for MT (drip-and-ship). We retrospectively analyzed 179 consecutive patients (93 in the mothership group and 86 in the drip-and-ship group), with AIS secondary to LVO in the anterior cerebral circulation and a clinical-radiological mismatch (NIHSS ≥ 8 and DWI-ASPECT score ≥5), up to 6 hours after symptoms onset. We evaluated 3-month functional modified Rankin scale (mRS), periprocedural time management, mortality, and symptomatic intracranial haemorrhage (sICH). Despite significant longer process time in the drip-and-ship group, mRS ≤ 2 at 3 months (39.8% versus 44.1%, P = .562), Thrombolysis in cerebral infarction 2b-3 (85% versus 78%, P = .256), and sICH (7.0% versus 9.7%, P = .515) were similar in both group regardless of baseline clinical or radiological characteristics. After multivariate logistic regression, the predictive factors for favorable outcome were age (odds ratio [OR] Our study showed encouraging results from a regional protocol of MT comparing patients transferred from PSC or brought directly in CSC.

Sections du résumé

BACKGROUND BACKGROUND
Mechanical thrombectomy (MT) in association with intravenous thrombolysis is recommended for treatment of acute ischemic stroke (AIS), with large vessel occlusion (LVO) in the anterior circulation. Because MT is only available in comprehensive stroke centers (CSC), the challenge of stroke organization is to ensure equitable access to the fastest endovascular suite. Our aim was to evaluate the feasibility, efficacy, and safety of MT in patients initially managed in 1 CSC (mothership), compared with patients first managed in primary stroke center (PSC), and then transferred to the CSC for MT (drip-and-ship).
METHODS METHODS
We retrospectively analyzed 179 consecutive patients (93 in the mothership group and 86 in the drip-and-ship group), with AIS secondary to LVO in the anterior cerebral circulation and a clinical-radiological mismatch (NIHSS ≥ 8 and DWI-ASPECT score ≥5), up to 6 hours after symptoms onset. We evaluated 3-month functional modified Rankin scale (mRS), periprocedural time management, mortality, and symptomatic intracranial haemorrhage (sICH).
RESULTS RESULTS
Despite significant longer process time in the drip-and-ship group, mRS ≤ 2 at 3 months (39.8% versus 44.1%, P = .562), Thrombolysis in cerebral infarction 2b-3 (85% versus 78%, P = .256), and sICH (7.0% versus 9.7%, P = .515) were similar in both group regardless of baseline clinical or radiological characteristics. After multivariate logistic regression, the predictive factors for favorable outcome were age (odds ratio [OR]
CONCLUSIONS CONCLUSIONS
Our study showed encouraging results from a regional protocol of MT comparing patients transferred from PSC or brought directly in CSC.

Identifiants

pubmed: 30442556
pii: S1052-3057(18)30573-1
doi: 10.1016/j.jstrokecerebrovasdis.2018.09.051
pii:
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

259-266

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Isabelle Mourand (I)

Department of Neurology, CHRU, Gui de Chauliac Hospital, Montpellier, France. Electronic address: i-mourand@chu-montpellier.fr.

Pauline Malissart (P)

Department of Neurology, CHRU, Gui de Chauliac Hospital, Montpellier, France. Electronic address: pauline.malissart@gmail.com.

Cyril Dargazanli (C)

Department of Neuroradiology, University Hospital Center, Montpellier, France. Electronic address: c-dargazanli@chu-montpellier.fr.

Erika Nogue (E)

Medical Information Department, University Hospital Center, Montpellier, France. Electronic address: e-nogue@chu-montpellier.fr.

Stephane Bouly (S)

Department of Neurology, Caremeau Hospital, Nimes, France. Electronic address: stephane.bouly@chu-nimes.fr.

Nicolas Gaillard (N)

Department of Neurology, CHRU, Gui de Chauliac Hospital, Montpellier, France; Department of Neurology, Hospital of Perpignan, France. Electronic address: n-gaillard@chu-montpellier.fr.

Yassine Boukriche (Y)

Department of Neurology, Hospital of Beziers, France. Electronic address: yassine.boukriche@ch-beziers.fr.

Lucas Corti (L)

Department of Neurology, CHRU, Gui de Chauliac Hospital, Montpellier, France. Electronic address: l-corti@chu-montpellier.fr.

Marie-Christine Picot (MC)

Medical Information Department, University Hospital Center, Montpellier, France. Electronic address: mc-picot@chu-montpellier.fr.

Olivier Beaufils (O)

Department of Emergency, University Hospital Center, Montpellier, France. Electronic address: o-beaufils@chu-montpellier.fr.

Mohamed Chbicheb (M)

Department of Neurology, Hospital of Narbonne, France. Electronic address: mohamed.chbicheb@ch-narbonne.fr.

Denis Sablot (D)

Department of Neurology, Hospital of Perpignan, France. Electronic address: denis.sablot@ch-perpignan.fr.

Alain Bonafe (A)

Department of Neuroradiology, University Hospital Center, Montpellier, France. Electronic address: a-bonafe@chu-montpellier.fr.

Vincent Costalat (V)

Department of Neuroradiology, University Hospital Center, Montpellier, France. Electronic address: v-costalat@chu-montpellier.fr.

Caroline Arquizan (C)

Department of Neurology, CHRU, Gui de Chauliac Hospital, Montpellier, France. Electronic address: c-arquizan@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH